Beverly Moy Selected Research

Beverly Moy Research Topics

Disease

87	Breast Neoplasms (Breast Cancer) 05/2024 - 11/2005
46	Neoplasms (Cancer) 05/2024 - 11/2005
9	Brain Neoplasms (Brain Tumor) 04/2023 - 11/2006
6	Disease Progression 01/2023 - 03/2016
6	Circulating Neoplastic Cells 01/2023 - 04/2013
4	Triple Negative Breast Neoplasms 05/2024 - 10/2021
4	Pathologic Complete Response 12/2022 - 10/2017
4	Diarrhea 01/2020 - 07/2007
3	Fatigue 06/2022 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2020
3	Exanthema (Rash) 04/2015 - 07/2007
2	Meningeal Carcinomatosis 08/2020 - 01/2020
2	Central Nervous System Diseases (CNS Diseases) 01/2020 - 03/2016
2	Neurologic Manifestations (Neurological Manifestations) 01/2019 - 03/2016
2	Pain (Aches) 12/2017 - 04/2015
2	Nausea 12/2017 - 03/2016
2	Vomiting 12/2017 - 03/2016
2	Cardiotoxicity 05/2011 - 07/2007
1	Alopecia (Baldness) 01/2023
1	Secretory breast carcinoma 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Rupture 08/2022
1	Chorioamnionitis 08/2022
1	Premature Birth (Birth, Premature) 08/2022
1	Microsatellite Instability 01/2022
1	Death (Near-Death Experience) 01/2022
1	Breakthrough Infections 01/2022

Drug/Important Bio-Agent (IBA)

22	Hormones (Hormone)IBA 01/2023 - 08/2006
19	Trastuzumab (Herceptin)FDA Link 01/2023 - 12/2009
14	human ERBB2 proteinIBA 01/2023 - 06/2010
12	neratinibIBA 01/2023 - 03/2016
12	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2006
12	Lapatinib (GW572016)FDA Link 11/2021 - 11/2006
10	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 11/2005
10	ErbB Receptors (EGF Receptor)IBA 01/2023 - 10/2014
6	Tyrosine Kinase InhibitorsIBA 01/2023 - 04/2014
6	Estrogen ReceptorsIBA 10/2020 - 10/2014
5	Capecitabine (Xeloda)FDA Link 12/2021 - 01/2019
4	Immunoconjugates (Immunoconjugate)IBA 05/2024 - 10/2021
4	Cell-Free Nucleic AcidsIBA 04/2023 - 01/2020
4	APTIBA 01/2023 - 06/2015
4	pembrolizumabIBA 01/2023 - 01/2020
3	sacituzumab govitecanIBA 05/2024 - 10/2021
3	Circulating Tumor DNAIBA 10/2023 - 11/2020
3	abemaciclibIBA 01/2023 - 01/2017
3	Cyclin-Dependent Kinase 4IBA 01/2023 - 01/2017
3	palbociclibIBA 01/2023 - 01/2017
3	Diphosphonates (Bisphosphonates)IBA 12/2022 - 06/2017
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2021 - 01/2017
3	Phenobarbital (Luminal)FDA Link 01/2019 - 10/2012
3	Aromatase InhibitorsIBA 01/2017 - 04/2014
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2024 - 01/2020
2	Denosumab FDA Link 12/2022 - 01/2022
2	Fulvestrant (Faslodex)FDA Link 01/2022 - 11/2019
2	Zoledronic Acid (Zometa)FDA Link 01/2022 - 06/2017
2	Clodronic Acid (Clodronate)IBA 01/2022 - 06/2017
2	AlpelisibIBA 01/2022 - 11/2019
2	AnthracyclinesIBA 12/2021 - 05/2011
2	taxaneIBA 12/2021 - 08/2021
2	AntigensIBA 10/2021 - 11/2020
2	ribociclibIBA 08/2021 - 01/2017
2	Loperamide (Imodium)FDA LinkGeneric 01/2020 - 03/2016
2	N,N- dimethyl- N- hexadecyl- 1- octadecylammonium (DDAC)IBA 12/2018 - 12/2009
2	Hemoglobins (Hemoglobin)IBA 02/2017 - 01/2013
2	exemestane (Aromasin)FDA Link 01/2017 - 04/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2016 - 11/2005
2	bosutinibIBA 04/2014 - 04/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2011 - 06/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2011 - 06/2010
1	talazoparibIBA 05/2024
1	B7-H1 AntigenIBA 01/2023
1	larotrectinibIBA 01/2023
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2023
1	entrectinibIBA 01/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2022
1	Taxoids (Taxanes)IBA 08/2022
1	Ibandronic Acid (Boniva)FDA Link 01/2022
1	AntibodiesIBA 01/2022
1	hydroxide ionIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	VaccinesIBA 01/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	dostarlimabIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2021
1	Monoclonal AntibodiesIBA 10/2021
1	Surface Antigens (Surface Antigen)IBA 10/2021

Therapy/Procedure

50	Therapeutics 05/2024 - 08/2006
29	Drug Therapy (Chemotherapy) 04/2024 - 11/2005
12	Adjuvant Chemotherapy 11/2023 - 11/2005
5	Neoadjuvant Therapy 12/2022 - 01/2013
4	Radiotherapy 01/2021 - 11/2013
4	Mastectomy (Mammectomy) 08/2020 - 01/2012
2	Drug Tapering 10/2023 - 06/2010
2	Aftercare (After-Treatment) 01/2023 - 08/2022
1	Precision Medicine 11/2023
1	Immunotherapy 01/2023
1	Terminal Care (Care, Terminal) 01/2022
1	Palliative Care (Palliative Therapy) 01/2022